IR Searcher

基本データ

【業種】: 化学
【市場】: プライム（内国株式）
【決算期】: 12月
【会社設立】
【上場】: 1999.4
【直近決算日】: 2025-05-09（1Q）
【決算予定日】: 2025-08-05 (15:30)

【時価総額】: 4106億9900万円
【PBR】: 1.89倍
【配当利回り(予)】: 1.98%

企業概要

小林製薬グループは、国内及び国際の幅広いヘルスケア・衛生用品事業を展開している。
主力製品としては、外用鎮痛消炎薬の「アンメルツ」や洗眼薬の「アイボン」、口腔衛生品の「タフデント」、日用消臭剤の「サワデー」などが挙げられる。
また、医薬品や栄養補助食品など、約150のブランドを有し、独自のアイデアを基にした製品開発に取り組んでいる。
通販を活用した販売戦略も展開しており、日用品や食品分野においても notableな成長を遂げている。
さらに、多数の子会社を通じてグローバル市場にも進出しており、国内外で確固たる地位を築いている。

業績修正履歴

年度	タイプ	日付	売上高	営業利益	経常利益	純利益
2023-12	新規	2023-02-14	172,000	25,500	26,500	20,200
2024-12	新規	2024-02-09	185,600	26,300	27,500	20,500
	変更	2024-05-10	未定	未定	未定	未定
	変更	2024-08-08	169,000	24,000	25,500	12,100
	変更	2024-11-08	169,000(→)	24,000(→)	25,500(→)	10,700(⬇)
今期	新規	2025-02-10	171,000	14,000	15,300	10,500

通期四半期別

売上高

経常利益

純利益

通期四半期別

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
	予想	171,000	14,000	15,300	10,500	141.25	8.19%	8.95%	3.26%	-43.68%	-43.04%	4.30%
2025-12	1	32,607	2,535	2,401	1,624	21.86	7.77%	7.36%	-10.6%	-49.6%	-56%	66.5%
2024-12	4	165,600	24,860	26,861	10,067	135.42	15.01%	16.22%	-4.5%	-3.6%	-1.7%	-50.5%
	3	114,459	16,976	17,921	5,344	71.9	14.83%	15.66%	-3.9%	-12.4%	-14%	-65.5%
	2	73,136	9,471	10,434	1,436	19.32	12.95%	14.27%	-0.7%	-9%	-6.6%	-81.7%
	1	36,485	5,028	5,461	976	13.13	13.78%	14.97%	9%	-0.6%	5.7%	-72.9%
2023-12	4	173,455	25,780	27,330	20,338	268.16	14.86%	15.76%	4.3%	-3.3%	-3.4%	1.6%
	3	119,115	19,387	20,837	15,498	203.64	16.28%	17.49%	4.2%	3.4%	2%	6.9%
	2	73,625	10,406	11,174	7,864	103.35	14.13%	15.18%	3.3%	5.5%	2.5%	2.1%
	1	33,467	5,061	5,168	3,608	47.43	15.12%	15.44%	2.5%	4.5%	1.3%	3.9%
2022-12	4	166,258	26,669	28,281	20,022	259.63	16.04%	17.01%	7.1%	2.3%	1%	1.6%
	3	114,279	18,749	20,433	14,500	187.52	16.41%	17.88%	6.1%	-3.5%	-2.8%	-2.6%
	2	71,264	9,868	10,904	7,700	99.55	13.85%	15.3%	6.3%	-3.6%	-1.7%	-2.3%
	1	32,646	4,845	5,100	3,473	44.87	14.84%	15.62%	7.9%	3.3%	-1.8%	-4.3%
2021-12	4	155,252	26,065	28,015	19,715	252.36	16.79%	18.04%	3.1%	0.5%	1%	2.7%
	3	107,658	19,426	21,016	14,883	190.42	18.04%	19.52%	2.5%	-0.5%	-0.1%	-2.5%
	2	67,052	10,240	11,091	7,881	100.84	15.27%	16.54%	1.3%	0.2%	0.6%	-4.1%
	1	30,269	4,689	5,192	3,628	46.42	15.49%	17.15%	-5.1%	-3.8%	3%	-3.1%
2020-12	4	150,514	25,943	27,726	19,205	245.71	17.24%	18.42%	-4.9%	1.1%	-0.4%	0.3%
	3	105,049	19,515	21,042	15,258	195.21	18.58%	20.03%	-5.5%	-1.6%	-1.9%	0.1%
	2	66,180	10,220	11,029	8,218	105.14	15.44%	16.67%	-4.5%	-8.2%	-5.2%	0.2%
	1	31,911	4,875	5,042	3,742	47.89	15.28%	15.8%	0.7%	-5.3%	-3.4%	1.6%
2019-12	4	168,052	26,355	27,851	19,139	244.08	15.68%	16.57%	0.3%	0.3%	1.7%	6.2%
	3	117,789	20,296	21,447	15,245	194.2	17.23%	18.21%	1.7%	3.7%	4.2%	10.7%
	2	73,630	11,421	11,635	8,202	104.26	15.51%	15.8%	1.3%	-1.6%	0.9%	7.5%
	1	33,735	5,287	5,219	3,683	46.65	15.67%	15.47%	0.1%	-5%	-3.6%	-3.6%
2018-12	4	167,479	26,289	27,374	18,023	228.05	15.7%	16.34%	6.8%	14.7%	13.2%	13.6%
	3	115,768	19,563	20,587	14,009	177.29	16.9%	17.78%	7.5%	14.1%	21.2%	19.3%
	2	72,678	11,602	11,533	7,629	96.58	15.96%	15.87%	8%	12%	12.6%	8.4%
	1	33,715	5,567	5,416	3,821	48.39	16.51%	16.06%	9.6%	12.3%	11.6%	10.6%
2017-12	4	156,761	22,925	24,191	15,863	201.31	14.62%	15.43%	―	―	―	―
	3	107,653	17,149	16,992	11,740	149.08	15.93%	15.78%	―	―	―	―
	2	67,307	10,363	10,244	7,037	89.44	15.4%	15.22%	―	―	―	―
	1	30,749	4,958	4,851	3,455	43.84	16.12%	15.78%	―	―	―	―
2016-12	4	120,051	17,409	19,499	14,321	179.12	14.5%	16.24%	―	―	―	―
	3		―	―	―	―	―	―	―	―	―	―
	2	74,366	11,861	11,646	8,109	101	15.95%	15.66%	―	―	―	―
	1	36,767	7,299	7,142	5,219	64.97	19.85%	19.43%	―	―	―	―

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
2025-12	1	32,607	2,535	2,401	1,624	21.86	7.77%	7.36%	-10.6%	-49.6%	-56%	66.5%
2024-12	4	51,141	7,884	8,940	4,723	63.52	15.42%	17.48%	-5.89%	23.32%	37.69%	-2.42%
	3	41,323	7,505	7,487	3,908	52.58	18.16%	18.12%	-9.16%	-16.43%	-22.52%	-48.81%
	2	36,651	4,443	4,973	460	6.19	12.12%	13.57%	-8.73%	-16.88%	-17.2%	-89.19%
	1	36,485	5,028	5,461	976	13.13	13.78%	14.97%	9%	-0.6%	5.7%	-72.9%
2023-12	4	54,340	6,393	6,493	4,840	64.52	11.76%	11.95%	4.54%	-19.28%	-17.27%	-12.35%
	3	45,490	8,981	9,663	7,634	100.29	19.74%	21.24%	5.75%	1.13%	1.41%	12.26%
	2	40,158	5,345	6,006	4,256	55.92	13.31%	14.96%	3.99%	6.41%	3.48%	0.69%
	1	33,467	5,061	5,168	3,608	47.43	15.12%	15.44%	2.5%	4.5%	1.3%	3.9%
2022-12	4	51,979	7,920	7,848	5,522	72.11	15.24%	15.1%	9.21%	19.3%	12.13%	14.28%
	3	43,015	8,881	9,529	6,800	87.97	20.65%	22.15%	5.93%	-3.32%	-3.99%	-2.88%
	2	38,618	5,023	5,804	4,227	54.68	13.01%	15.03%	4.99%	-9.51%	-1.61%	-0.61%
	1	32,646	4,845	5,100	3,473	44.87	14.84%	15.62%	7.9%	3.3%	-1.8%	-4.3%
2021-12	4	47,594	6,639	6,999	4,832	61.94	13.95%	14.71%	4.68%	3.28%	4.71%	22.42%
	3	40,606	9,186	9,925	7,002	89.58	22.62%	24.44%	4.47%	-1.17%	-0.88%	-0.54%
	2	36,783	5,551	5,899	4,253	54.42	15.09%	16.04%	7.34%	3.85%	-1.47%	-4.98%
	1	30,269	4,689	5,192	3,628	46.42	15.49%	17.15%	-5.1%	-3.8%	3%	-3.1%
2020-12	4	45,465	6,428	6,684	3,947	50.5	14.14%	14.7%	-9.55%	6.09%	4.37%	1.36%
	3	38,869	9,295	10,013	7,040	90.07	23.91%	25.76%	-11.98%	4.73%	2.05%	-0.04%
	2	34,269	5,345	5,987	4,476	57.25	15.6%	17.47%	-14.1%	-12.86%	-6.69%	-0.95%
	1	31,911	4,875	5,042	3,742	47.89	15.28%	15.8%	0.7%	-5.3%	-3.4%	1.6%
2019-12	4	50,263	6,059	6,404	3,894	49.88	12.05%	12.74%	-2.8%	-9.92%	-5.64%	-2.99%
	3	44,159	8,875	9,812	7,043	89.94	20.1%	22.22%	2.48%	11.48%	8.37%	10.39%
	2	39,895	6,134	6,416	4,519	57.61	15.38%	16.08%	2.39%	1.64%	4.89%	18.67%
	1	33,735	5,287	5,219	3,683	46.65	15.67%	15.47%	0.1%	-5%	-3.6%	-3.6%
2018-12	4	51,711	6,726	6,787	4,014	50.76	13.01%	13.12%	5.3%	16.45%	-5.72%	-2.64%
	3	43,090	7,961	9,054	6,380	80.71	18.48%	21.01%	6.8%	17.32%	34.17%	35.66%
	2	38,963	6,035	6,117	3,808	48.19	15.49%	15.7%	6.58%	11.66%	13.42%	6.31%
	1	33,715	5,567	5,416	3,821	48.39	16.51%	16.06%	9.6%	12.3%	11.6%	10.6%
2017-12	4	49,108	5,776	7,199	4,123	52.23	11.76%	14.66%	―	―	―	―
	3	40,346	6,786	6,748	4,703	59.64	16.82%	16.73%	―	―	―	―
	2	36,558	5,405	5,393	3,582	45.6	14.78%	14.75%	―	―	―	―
	1	30,749	4,958	4,851	3,455	43.84	16.12%	15.78%	―	―	―	―
2016-12	4		―	―	―	―	―	―	―	―	―	―
	3		―	―	―	―	―	―	―	―	―	―
	2	37,599	4,562	4,504	2,890	36.03	12.13%	11.98%	―	―	―	―
	1	36,767	7,299	7,142	5,219	64.97	19.85%	19.43%	―	―	―	―

4967 小林製薬 企業サイト Yahooファイナンス 日経新聞 株探 四季報

4967 小林製薬　企業サイト　　　Yahooファイナンス　日経新聞　株探　四季報　